Burning Rock Biotech
46 hedge funds and large institutions have $274M invested in Burning Rock Biotech in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 15 increasing their positions, 20 reducing their positions, and 19 closing their positions.
13% more capital invested
Capital invested by funds: $243M → $274M (+$31.4M)
0.33% more ownership
Funds ownership: 3.06% → 3.38% (+0.33%)
25% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 20
26% less funds holding
Funds holding: 62 → 46 (-16)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
84% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 19
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$23.2M |
| 2 |
NAMA
Nikko Asset Management Americas
New York
|
+$8.29M |
| 3 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$8.29M |
| 4 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
+$3.39M |
| 5 |
Morgan Stanley
New York
|
+$3.14M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$11.8M |
| 2 |
Millennium Management
New York
|
-$3.44M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$2.1M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$1.77M |
| 5 |
SP
Sage Partners
Hong Kong
|
-$1.66M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Goldman Sachs
New York
| – | -$387K | -4,066 | Closed |
|
|
CIP
52
Champlain Investment Partners
Burlington,
Vermont
| – | -$270K | -2,834 | Closed |
|
|
EPAM
53
Euro Pacific Asset Management
Dorado,
Puerto Rico
| – | -$261K | -2,741 | Closed |
|
|
NEI
54
Northwest & Ethical Investments
Toronto,
Ontario, Canada
| – | -$196K | -2,060 | Closed |
|
55
Two Sigma Advisers
New York
| – | -$167K | -1,750 | Closed |
|
|
PCM
56
Prelude Capital Management
New York
| – | -$119K | -1,250 | Closed |
|
57
Marshall Wace
London,
United Kingdom
| – | -$83K | -868 | Closed |
|
58
Ensign Peak Advisors
Salt Lake City,
Utah
| – | -$29K | -305 | Closed |
|
59
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$20K | -214 | Closed |
|
|
QT
60
Quantbot Technologies
New York
| – | -$18K | -190 | Closed |
|
61
Allspring Global Investments
Charlotte,
North Carolina
| – | -$9K | -97 | Closed |
|
62
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$2K | -22 | Closed |
|
63
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$1.48K | -17 | -85% |
|
|
KFA
64
Krane Funds Advisors
New York
| – | -$1K | -14 | Closed |
|
BNR Hedge Fund Activity: Q1 2022 in Review
46 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Burning Rock Biotech (BNR) for Q1 2022, worth a combined $274M — up 13% from $243M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of BNR and 3 opened new positions — a net loss of 16 holders — while 20 trimmed existing stakes and 15 added.
The largest buyer was ARK Investment Management, adding an estimated $23.2M. The largest seller was Canada Pension Plan Investment Board, exiting entirely with an estimated $11.8M sold.
- 46 institutional investors held Burning Rock Biotech (BNR) as of Q1 2022, down from 62 in Q4 2021.
- Funds reported $274M of Burning Rock Biotech stock for Q1 2022, up 13% quarter-over-quarter.
- 3 funds opened new Burning Rock Biotech positions in Q1 2022 and 19 closed out, a net change of -16 holders.
- The largest Burning Rock Biotech buyer in Q1 2022 was ARK Investment Management, an estimated $23.2M added.
- The largest Burning Rock Biotech seller in Q1 2022 was Canada Pension Plan Investment Board, an estimated $11.8M sold.
Based on aggregated 13F filings for Q1 2022.